# EDGAR Filing Document

**Accession Number:** 0000863894
**File Stem:** 0001437749-25-023521
**Filing Date:** 2025-7
**Character Count:** 5339
**Document Hash:** 05ff97d5bcea221f8bcdaf56ec7539fa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-023521.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0001437749-25-023521

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250725

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250725

**DATE AS OF CHANGE**: 20250725

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VERU INC.
- **CENTRAL INDEX KEY:** 0000863894
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 391144397
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13602
- **FILM NUMBER:** 251151756

**BUSINESS ADDRESS:**
- **STREET 1:** 2916 N. MIAMI AVENUE
- **STREET 2:** SUITE 1000
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33127
- **BUSINESS PHONE:** 3125959123

**MAIL ADDRESS:**
- **STREET 1:** 2916 N. MIAMI AVENUE
- **STREET 2:** SUITE 1000
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33127

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEMALE HEALTH CO
- **DATE OF NAME CHANGE:** 19960205

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WISCONSIN PHARMACAL COMPANY INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? veru20250724c_8k.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**FORM 8-K**

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): <u>July 25, 2025</u>**

------

## VERU INC.
(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Wisconsin** | **1-13602** | **39-1144397** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127**

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: **<u>(305) 509-6897</u>**

**Not Applicable**

(Former name or former address, if changed since last report.)

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value per share | VERU | NASDAQ Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Section 5** – **Corporate Governance and Management**

**Item 5.07.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Submission of Matters to a Vote of Security Holders.**

A special meeting of the shareholders of the Company (the "Special Meeting") was held on July 25, 2025. A total of 146,583,920 shares of the Company's common stock were eligible to vote at the Special Meeting. The matters voted on at the Special Meeting were as follows:

1. Reverse Stock Split Proposal:

The shareholders voted to approve an amendment to the Company's Amended and Restated Articles of Incorporation to effect a reverse stock split at a ratio to be determined by the Board of Directors within a range of 1-for-2 to 1-for-20.

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u>  | <u>Votes Against</u>  | <u>Abstentions</u>  | &nbsp;&nbsp;&nbsp;&nbsp;<u>Broker Non-Votes</u>  |
| 98,869,209 | 7,080,957 | 1,013,920 | 0 |

---

2. Adjournment Proposal:

The shareholders voted in favor of approving the adjournment of the Special Meeting.

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u>  | &nbsp;&nbsp;&nbsp;&nbsp;<u>Votes Against</u>  | <u>Abstentions</u>  | &nbsp;&nbsp;&nbsp;&nbsp;<u>Broker Non-Votes</u>  |
| 100,083,638 | 6,212,862 | 667,586 | 0 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: July 25, 2025 | VERU INC. | VERU INC. |
|  | By:  | /s/ Michele Greco |
|  |  | Michele Greco |
|  |  | Chief Financial Officer and<br> Chief Administrative Officer |

---